| 000 | 01516 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512080503.0 | ||
| 264 | 0 | _c19850305 | |
| 008 | 198503s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1093/infdis/151.2.295 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevine, J F | |
| 245 | 0 | 0 |
_aAmikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cFeb 1985 |
||
| 300 |
_a295-300 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetyltransferases _xmetabolism |
| 650 | 0 | 4 |
_aAmikacin _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aEnterobacteriaceae _xdrug effects |
| 650 | 0 | 4 |
_aEnterobacteriaceae Infections _xdrug therapy |
| 650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKanamycin _xanalogs & derivatives |
| 650 | 0 | 4 | _aNew York |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
| 650 | 0 | 4 | _aR Factors |
| 700 | 1 | _aMaslow, M J | |
| 700 | 1 | _aLeibowitz, R E | |
| 700 | 1 | _aPollock, A A | |
| 700 | 1 | _aHanna, B A | |
| 700 | 1 | _aSchaefler, S | |
| 700 | 1 | _aSimberkoff, M S | |
| 700 | 1 | _aRahal, J J | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 151 _gno. 2 _gp. 295-300 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/151.2.295 _zAvailable from publisher's website |
| 999 |
_c3923810 _d3923810 |
||